Last edition
News about
Under the agreement, Blackstone will provide Merck with USD 700 million in non-refundable funding to support a portion of the development costs expected through 2026.
Cipla to Acquire Inzpera Healthsciences for INR 110 Crore
Cipla Limited has announced that it will acquire a 100 percent stake in Inzpera Healthsciences Limited for a total consideration of approximately INR 110 crore.
Roche's Gazyva/Gazyvaro Shows Positive Results for Systemic Lupus Erythematosus in Phase III trials
The ALLEGORY study met its primary endpoint showing a higher percentage of people achieved a minimum four-point improvement in SLE Responder Index 4 (SRI-4) at one year (52 weeks) with Gazyva/Gazyvaro versus standard therapy.
Eli Lilly has announced plans to invest USD 3 billion in a new manufacturing facility in Katwijk, the Netherlands, to expand its global capacity for producing oral medicines and strengthen its supply chain network.
PBS Biotech Appoints Martin Simonetti as CEO
Simonetti is a veteran biotech executive who brings more than 40 years' industry expertise and leadership to PBS Biotech, including C-suite leadership, public and private financing and executing large-scale pharmaceutical collaborations.
Merz Aesthetics Unveils Ergonomically Designed Belotero Syringe for Enhanced Precision and Comfort
The syringe has been engineered to provide greater precision, comfort, and control, enhancing the overall treatment experience for both practitioners and patients. It will first be introduced in Europe before a phased rollout across global markets.
Kimberly-Clark to Acquire Tylenol Maker Kenvue in Over 40 Billion Dollar Deal
Kimberly-Clark has announced plans to acquire Kenvue, the company behind Tylenol and other well-known consumer health brands, in a cash-and-stock transaction valued at approximately 48.7 billion dollars.
AIxMed and PathNet Partner to Advance Digital Pathology with AI-Driven Urine Cytology
AIxMed has partnered with PathNet to advance digital pathology through its AIxURO solution, an AI-powered platform designed to enhance the analysis of non-invasive urine cytology samples. The collaboration aims to boost diagnostic accuracy and streamline workflows in bladder cancer detection.
Johnson & Johnson MedTech has released the one-year results of its DISRUPT BTK II study, reaffirming the safety and durability of the Shockwave Peripheral Intravascular Lithotripsy (IVL) System for the treatment of calcified below-the-knee (BTK) lesions in patients with peripheral artery disease (PA
UCB Wins FDA Approval for KYGEVVI, First-Ever Treatment for Thymidine Kinase 2 Deficiency
UCB, the Brussels-based multinational biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for KYGEVVI (doxecitine and doxribtimine), marking the first and only approved treatment for thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients whose symptoms began at or before 12 years of age.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy